Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains

J Infect Dev Ctries. 2009 Apr 30;3(3):159-61. doi: 10.3855/jidc.18.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Humans
  • Influenza A Virus, H1N1 Subtype / isolation & purification*
  • Influenza, Human / complications*
  • Influenza, Human / drug therapy*
  • Influenza, Human / virology
  • Macrolides / therapeutic use*
  • Pneumonia, Bacterial / complications*
  • Pneumonia, Bacterial / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Macrolides